Endurance Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-300	Closed	-$34K	–	632
2021 Q3	$34K	Hold	300	–	–	﹤0.01%	389
2021 Q2	$48K	Hold	300	–	–	0.01%	363
2021 Q1	$37K	Buy	+300	New	+$37K	﹤0.01%	387